the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Injectable Generic Drugs: Prospects and Opportunities to 2013

Published by Espicom Business Intelligence Contact us : +1-860-674-8796
Published 2008/07 Content info 264+ PAGES
Product code ES70713
Price From  US $ 2460 Order/Price list
US $ 2460 Hard Copy
US $ 2460 PDF by E-mail (Single User License)
US $ 2460 Web Access (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

This report will provide industry planners, commercial developers and the investment community with a thorough review of the operating landscape for generic injectables. The report is packed with primary source information and market forecasts, and takes a balanced view of the players and products that will shape this high value market sector.

Key therapy sectors covered...

  • Cancer
  • CNS
  • Cardiovascular
  • Anti-Infectives
  • Diabetes
  • Growth Disorders

Companies analysed in this report

  • Amphastar Pharmaceuticals
  • Apotex
  • APP Pharmaceuticals
  • Baxter Healthcare
  • Bedford Laboratories
  • Hikma Pharmaceuticals
  • Hospira
  • Orchid Healthcare
  • Paddock Laboratories
  • PharmaForce
  • Sagent Pharmaceuticals
  • Sandoz
  • Sun Pharma
  • Teva Pharmaceutical Industries
  • Wockhardt
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.